An inflammatory-related genes signature based model for prognosis prediction in breast cancer

por FU, JINGYUE, CHEN, RUI, ZHANG, ZHIZHENG, ZHAO, JIANYI, XIA, TIANSONG
Publicado 2023

High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancer

por Chen, Rui, Wang, Xinyang, Fu, Jingyue, Liang, Mengdi, Xia, Tiansong
Publicado 2022

RUNX regulated immune-associated genes predicts prognosis in breast cancer

por Fu, Jingyue, Sun, Handong, Xu, Feng, Chen, Rui, Wang, Xinyang, Ding, Qiang, Xia, Tiansong
Publicado 2022

ncRNAs-mediated high expression of TIMM8A correlates with poor prognosis and act as an oncogene in breast cancer

por Wang, Zhonglin, Li, Shuqin, Xu, Feng, Fu, Jingyue, Sun, Jie, Gan, XinLi, Yang, Chuang, Mao, Zhongqi
Publicado 2022

miR-1275 targets MDK/AKT signaling to inhibit breast cancer chemoresistance by lessening the properties of cancer stem cells

por Han, Xu, Li, Minghui, Xu, Jin, Fu, Jingyue, Wang, Xinyang, Wang, Jingyi, Xia, Tiansong, Wang, Shui, Ma, Ge
Publicado 2023

Morroniside Inhibits Inflammatory Bone Loss through the TRAF6-Mediated NF-κB/MAPK Signalling Pathway

por Xiao, Jirimutu, Han, Qiuge, Yu, Ziceng, Liu, Mengmin, Sun, Jie, Wu, Mao, Yin, Heng, Fu, Jingyue, Guo, Yang, Wang, Lining, Ma, Yong
Publicado 2023